Citryl-imine-PEG-ylated chitosan hydrogels - Promising materials for drug delivery applications
Copyright © 2020 Elsevier B.V. All rights reserved..
The present paper focuses on the synthesis and characterization of new hydrogels and drug delivery systems, designed for local therapy. The hydrogels were obtained by reacting PEG-ylated chitosan derivatives with citral in different molar ratios of their functionalities. The drug delivery systems were obtained by the in situ hydrogelation of PEG-ylated chitosan derivatives with citral, in the presence of a hydrophilic anti-inflammatory drug, diclofenac sodium salt. The hydrogels and the drug delivery systems were characterized from the structural, supramolecular and morphological points of view by FTIR spectroscopy, wide angle X-ray diffraction, polarized optical microscopy and scanning electron microscopy. The in vitro release kinetics of the drug has been monitored in physiological conditions, while the in vivo release was evaluated by the somatic pain model on rats. The in vitro enzymatic degradability of the hydrogels was evaluated in the presence of lysozyme, leading to a significant mass loss of 47% in 21 days. All the findings, recommend the investigated materials as promising candidates for local drug delivery applications.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:162 |
---|---|
Enthalten in: |
International journal of biological macromolecules - 162(2020) vom: 01. Nov., Seite 1323-1337 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ailincai, Daniela [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 25.03.2021 Date Revised 25.03.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ijbiomac.2020.06.218 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM311773168 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM311773168 | ||
003 | DE-627 | ||
005 | 20231225142956.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijbiomac.2020.06.218 |2 doi | |
028 | 5 | 2 | |a pubmed24n1039.xml |
035 | |a (DE-627)NLM311773168 | ||
035 | |a (NLM)32599243 | ||
035 | |a (PII)S0141-8130(20)33674-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ailincai, Daniela |e verfasserin |4 aut | |
245 | 1 | 0 | |a Citryl-imine-PEG-ylated chitosan hydrogels - Promising materials for drug delivery applications |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.03.2021 | ||
500 | |a Date Revised 25.03.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Elsevier B.V. All rights reserved. | ||
520 | |a The present paper focuses on the synthesis and characterization of new hydrogels and drug delivery systems, designed for local therapy. The hydrogels were obtained by reacting PEG-ylated chitosan derivatives with citral in different molar ratios of their functionalities. The drug delivery systems were obtained by the in situ hydrogelation of PEG-ylated chitosan derivatives with citral, in the presence of a hydrophilic anti-inflammatory drug, diclofenac sodium salt. The hydrogels and the drug delivery systems were characterized from the structural, supramolecular and morphological points of view by FTIR spectroscopy, wide angle X-ray diffraction, polarized optical microscopy and scanning electron microscopy. The in vitro release kinetics of the drug has been monitored in physiological conditions, while the in vivo release was evaluated by the somatic pain model on rats. The in vitro enzymatic degradability of the hydrogels was evaluated in the presence of lysozyme, leading to a significant mass loss of 47% in 21 days. All the findings, recommend the investigated materials as promising candidates for local drug delivery applications | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Antinociceptive effect | |
650 | 4 | |a Biocompatibility | |
650 | 4 | |a Chitosan hydrogels | |
650 | 4 | |a Local drug delivery | |
650 | 4 | |a PEG-ylation | |
650 | 4 | |a Sustained drug release | |
650 | 7 | |a Hydrogels |2 NLM | |
650 | 7 | |a Diclofenac |2 NLM | |
650 | 7 | |a 144O8QL0L1 |2 NLM | |
650 | 7 | |a Polyethylene Glycols |2 NLM | |
650 | 7 | |a 3WJQ0SDW1A |2 NLM | |
650 | 7 | |a Chitosan |2 NLM | |
650 | 7 | |a 9012-76-4 |2 NLM | |
700 | 1 | |a Mititelu-Tartau, Liliana |e verfasserin |4 aut | |
700 | 1 | |a Marin, Luminita |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of biological macromolecules |d 1992 |g 162(2020) vom: 01. Nov., Seite 1323-1337 |w (DE-627)NLM012627356 |x 1879-0003 |7 nnns |
773 | 1 | 8 | |g volume:162 |g year:2020 |g day:01 |g month:11 |g pages:1323-1337 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijbiomac.2020.06.218 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 162 |j 2020 |b 01 |c 11 |h 1323-1337 |